Top 5 Startups & Unicorns companies in Diabetic neuropathy by Highest Patent Value in the world in 2022 – Discovery

Free Trial

The Diabetic neuropathy top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Diabetic neuropathy Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	STARTUP Cuorips, Inc.	Hokkaido, Japan	Stem cell,Medical equipment,Health care	Avg patent value: 4.26 M
2	STARTUP infirst Healthcare Ltd.	United Kingdom	Gastrointestinal agent,Health care,Niquitin, ...[+2]	Avg patent value: 4.04 M
3	STARTUP Hope Medicine, Inc.	Jiangsu Sheng, China	Biopharmaceutical,Health care,Drug, ...[+2]	Avg patent value: 100,000
4	STARTUP Cersci Therapeutics, Inc.	Texas, United States	Biology,Neuroscience,Pharmacy and Therapeutics, ...[+2]	Avg patent value: 75,250
5	STARTUP Cellix Bio Pvt Ltd.	New Jersey, United States	Health care,Drug,Medical research, ...[+2]	Avg patent value: 69,000